Wai Yuen Tong Medicine Holdings (HKSE:00897) Change In Receivables : HK$0 Mil (TTM As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Change In Receivables?

Wai Yuen Tong Medicine Holdings's change in receivables for the quarter that ended in Sep. 2023 was HK$0 Mil. It means Wai Yuen Tong Medicine Holdings's Accounts Receivable stayed the same from Mar. 2023 to Sep. 2023 .

Wai Yuen Tong Medicine Holdings's change in receivables for the fiscal year that ended in Mar. 2023 was HK$-14 Mil. It means Wai Yuen Tong Medicine Holdings's Accounts Receivable increased by HK$14 Mil from Mar. 2022 to Mar. 2023 .

Wai Yuen Tong Medicine Holdings's Accounts Receivable for the quarter that ended in Sep. 2023 was HK$67 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Wai Yuen Tong Medicine Holdings's Days Sales Outstanding for the six months ended in Sep. 2023 was 17.90.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Wai Yuen Tong Medicine Holdings's liquidation value for the six months ended in Sep. 2023 was HK$-1,737 Mil.

Wai Yuen Tong Medicine Holdings Change In Receivables Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Change In Receivables Chart

Wai Yuen Tong Medicine Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

17.48

19.88

16.49

-14.43

-14.00

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Wai Yuen Tong Medicine Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Wai Yuen Tong Medicine Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	66.566	/	678.804	*	91
=	17.90

2. In Ben Graham's calculation of liquidation value, Wai Yuen Tong Medicine Holdings's accounts receivable are only considered to be worth 75% of book value:

Wai Yuen Tong Medicine Holdings's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	505.423	-	3098.226	+	0.75 * 66.566	+	0.5 * 1611.006
=	-1,737

Wai Yuen Tong Medicine Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG

Website

https://www.wyth.net

Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.

Executives

Wang On Group Limited	2501 Other
Tang Ching Ho	2501 Other
Yau Yuk Yin	2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines